Estimated Primary end date August 2020 and Trial completion December 2020 as per trial info:
https://clinicaltrials.gov/ct2/show/NCT02795988?term=Imugene&rank=1
Possibly we may go directly into Phase 3, who knows at this stage & it’s entirely possible that Her-Vaxx maybe the IP of Big Pharma by that stage. It’s really encouraging that we are going directly into Ph2 with seemingly good results from 1b. Top line results due out Dec 2018. Here’s a good basic article on part of what Imugene are doing at the moment with Her-Vaxx & a lot more in the R&D pipeline:
https://smallcaps.com.au/imugene-receives-tax-rebate-ongoing-gastric-cancer-trials/
GLTA
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-98
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
